BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33173638)

  • 1. Anti-Lan Antibodies: A Rare Etiology of Severe Blood Transfusion Reaction.
    Sharma P; Manthri S; Patterson E; Youssef B; Chakraborty K
    Cureus; 2020 Oct; 12(10):e10832. PubMed ID: 33173638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN; Young NG; Erickson ML; Prats I
    BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic disease of the fetus and newborn caused by anti-Lan.
    Brooks S; Squires JE
    Transfusion; 2014 May; 54(5):1317-20. PubMed ID: 24188628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
    Irani MS; Karafin MS; Ernster L
    J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LAN blood group system:a review.
    Peyrard T
    Immunohematology; 2013; 29(4):131-5. PubMed ID: 24689682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction.
    Stroncek D; Procter JL; Johnson J
    Am J Hematol; 2000 May; 64(1):67-70. PubMed ID: 10815791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex Transfusion Management in a Sickle Cell Patient With Anti-Fy3 Alloimmunization: A Case Report.
    Claesen K; Heyrman B; De Schouwer P; Mahieu S
    Cureus; 2024 May; 16(5):e60939. PubMed ID: 38910632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rare holley antibody associated with a severe hemolytic transfusion reaction: the importance of this antibody identification to find a compatible blood unit.
    Santos LD; Bub CB; Aravechia MG; Bastos EP; Kutner JM; Castilho L
    Einstein (Sao Paulo); 2020; 18():eRC4582. PubMed ID: 31531557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Jk3 in a Filipino man.
    McCaskill S; Wise S; Tinsley S
    Immunohematology; 2015; 31(3):119-22. PubMed ID: 26829178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-M-Induced Delayed Hemolytic Transfusion Reaction.
    Fadeyi EA; Naal T; Green M; Simmons JH; Jones MR; Pomper GJ
    Lab Med; 2020 Jul; 51(4):426-429. PubMed ID: 31756244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
    Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notorious anti-Jk3 in a pregnant woman.
    Jator EK
    Clin Lab Sci; 2014; 27(2):78-82. PubMed ID: 25000650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.
    Strupp A; Cash K; Uehlinger J
    Transfusion; 1998; 38(11-12):1022-5. PubMed ID: 9838931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemolytic transfusion reaction due to anti-Le(b).
    Irani MS; Figueroa D; Savage G
    Transfusion; 2015 Oct; 55(10):2486-8. PubMed ID: 26018602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A suspected delayed hemolytic transfusion reaction mediated by anti-Joa.
    Jajosky RP; Lumm WC; Wise SC; Bollag RJ; Shikle JF
    Immunohematology; 2017 Jun; 33(2):73-75. PubMed ID: 28657766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Delayed hemolytic transfusion reaction caused by an anti-U].
    Taliano V; Fleury M; Pichette R; Lamothe M; Décary F
    Rev Fr Transfus Hemobiol; 1989 Feb; 32(1):17-26. PubMed ID: 2719776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hemolytic transfusion reaction due to anti-Jk(a).
    Vucelic D; Savic N; Djordjevic R
    Acta Chir Iugosl; 2005; 52(3):111-5. PubMed ID: 16813007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusion management of patients with alloanti-Gerbich antibodies: case report].
    Jovanović R; Bujandrić N; Lisulov S; Bogdanović S
    Srp Arh Celok Lek; 2011; 139(7-8):518-22. PubMed ID: 21980665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusions of least-incompatible blood with intravenous immunoglobulin plus steroids cover in two patients with rare antibody.
    Win N; Needs M; Thornton N; Webster R; Chang C
    Transfusion; 2018 Jul; 58(7):1626-1630. PubMed ID: 29732576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of antibodies to antigens in the Raph, John Milton Hagen, I, Globoside, Gill, Rh-associated glycoprotein, FORS, JR, LAN, Vel, CD59, and Augustine blood group systems.
    Moghaddam M; Naghi AA
    Immunohematology; 2018 Sep; 34(3):85-90. PubMed ID: 30295501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.